260441-44-9 Usage
Uses
Used in Chemical Research:
2-(PIPERIDIN-4-YL-OXY)-5-CHLOROPYRIDINE is used as a research compound for exploring its reactivity and potential applications in various chemical processes. Its unique structure, consisting of a piperidinyl group and a chloropyridine moiety connected by an ether linkage, makes it a valuable subject for scientific investigation.
Used in Pharmaceutical Development:
Although specific applications are not well-documented, 2-(PIPERIDIN-4-YL-OXY)-5-CHLOROPYRIDINE may be used as a starting material or intermediate in the development of pharmaceutical compounds. Its structural features could potentially contribute to the creation of new drugs with specific therapeutic properties.
Used in Material Science:
2-(PIPERIDIN-4-YL-OXY)-5-CHLOROPYRIDINE's reactivity and structural characteristics may also make it suitable for use in material science, where it could be explored for its potential to form new materials or contribute to the modification of existing ones.
Check Digit Verification of cas no
The CAS Registry Mumber 260441-44-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,0,4,4 and 1 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 260441-44:
(8*2)+(7*6)+(6*0)+(5*4)+(4*4)+(3*1)+(2*4)+(1*4)=109
109 % 10 = 9
So 260441-44-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H13ClN2O/c11-8-1-2-10(13-7-8)14-9-3-5-12-6-4-9/h1-2,7,9,12H,3-6H2
260441-44-9Relevant academic research and scientific papers
NOVEL CRYSTAL MODIFICATIONS
-
Page/Page column 47, (2008/06/13)
Novel crystal modifications of (5S)-5-[4-(5-chloro-pyridin-2-yloxy)-piperidine-1-sulfonylmethyl]-5-methyl-imidazolidine-2,4-dione are disclosed together with processes for preparing such modifications, pharmaceutical compositions comprising such a modification, and the use of such a modification in therapy.
TRIAZOLONE DERIVATIVES AS MMP INHIBITORS FOR THE TREATMENT OF ASTHMA AND COPD
-
Page/Page column 34, (2008/06/13)
The invention provides compounds of formula (I): wherein R1, R2, R3, R4, R5, X, Y, L, G1 and m have the meanings defined in the specification; processes for their preparation; pharmaceutica
NOVEL AZA-RING DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS
-
Page 16-18, (2008/06/13)
This invention relates to novel aza-dng dedvatives useful as monoamine neurotransmifter re-uptake inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)
-
Page/Page column 41, (2010/02/06)
Arylpiperazines of formula (I) useful as metalloproteinase inhibitors, especially as inhibitors of MMP 13.
